Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Century Therapeutics brings in $250mm via Series A

Executive Summary

Cell therapy start-up Century Therapeutics raised $250mm through its Series A round. Bayer AG, through its newly minted Leaps by Bayer venture investment arm, led with a $215mm investment and was joined by founder and seed investor Versant Ventures along with partner Fujifilm Cellular Dynamics.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Gene Therapy, Cell Therapy
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies